Current Medicinal Chemistry

This journal supports open access

Editor-in-Chief:

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK

Back

Become EABM
Become Reviewer

Proteasome Inhibition: A Promising Strategy for Treating Cancer, but What About Neurotoxicity?

Volume:15   Issue: 29
Pp: 3025-3035
A. Gilardini, P. Marmiroli and G. Cavaletti
DOI: 10.2174/092986708786848622

Targeted Drugs in Chronic Myeloid Leukemia

Volume:15   Issue: 29
Pp: 3036-3051
Joanna Gora-Tybor and Tadeusz Robak
DOI: 10.2174/092986708786848578

“Cancer Antigen WT1 Protein-Derived Peptide”-Based Treatment of Cancer -Toward the Further Development

Volume:15   Issue: 29
Pp: 3052-3061
Yoshihiro Oka, Akihiro Tsuboi, Fumihiro Fujiki, Toshiaki Shirakata, Sumiyuki Nishida, Naoki Hosen, Hiroko Nakajima, Zheyu Li, Ichiro Kawase, Yusuke Oji and Haruo Sugiyama
DOI: 10.2174/092986708786848631

Regulation of Tumor-Stromal Fibroblast Interactions: Implications in Anticancer Therapy

Volume:15   Issue: 29
Pp: 3062-3067
Hippokratis Kiaris, George Trimis and Athanasios G. Papavassiliou
DOI: 10.2174/092986708786848596

Antioxidants and Neuroprotection in the Adult and Developing Central Nervous System

Volume:15   Issue: 29
Pp: 3068-3080
Charanjit Kaur and Eng-Ang Ling
DOI: 10.2174/092986708786848640

Mechanisms Underlying Chemotherapy-Induced Neurotoxicity and the Potential for Neuroprotective Strategies

Volume:15   Issue: 29
Pp: 3081-3094
S. B. Park, A. V. Krishnan, C. S-Y. Lin, D. Goldstein, M. Friedlander and M. C. Kiernan
DOI: 10.2174/092986708786848569

Small Molecules ATP-Competitive Inhibitors of FLT3: A Chemical Overview

Volume:15   Issue: 29
Pp: 3113-3132
S. Schenone, C. Brullo and M. Botta
DOI: 10.2174/092986708786848613